1 d, and 1 each had a gastrinoma, glucagonoma,
fibrolamellar cancer, and malignant histiocytoma.
2 Fibrolamellar carcinoma (FLC) is a rare liver cancer.
3 Fibrolamellar carcinoma (FLC) is a rare liver tumor driv
4 Fibrolamellar carcinoma (FLC) is a type of primary liver
5 Fibrolamellar carcinoma (FLC) is a unique liver cancer p
6 Fibrolamellar carcinoma (FLC) is characterized by in-fra
7 dent cancer models: a novel, patient-derived
fibrolamellar carcinoma (FLC) line that expresses a DNAJ
8 Fibrolamellar carcinoma (FLC), a unique HCC subtype, exh
9 function using uniporter knockout cells and
fibrolamellar carcinoma (FLC), which we demonstrate to h
10 epidemiology and prognosis of patients with
fibrolamellar carcinoma (FLC).
11 inoma (iCCA), and other rare tumors, notably
fibrolamellar carcinoma and hepatoblastoma.
12 Patients with
fibrolamellar carcinoma, sarcomatoid hepatocellular carc
13 vascularized woven-parallel complexes, with
fibrolamellar complexes during early to mid-ontogeny, co
14 Frozen HCCs (n = 32), including five
fibrolamellar (
FL) variants, and control livers (n = 3)
15 54-beta-catenin were exclusively observed in
fibrolamellar (
FL)-HCC cases.
16 Forty-three patients with HCC (34), and
fibrolamellar HCC (FLHCC; nine) were treated with contin
17 surgical resection may be helpful to control
fibrolamellar HCC and to prolong survival in appropriate
18 Fibrolamellar HCC frequently demonstrates aggressive loc
19 Fibrolamellar HCC is a rare variant of classic HCC with
20 Thirty-one patients with
fibrolamellar HCC underwent pretherapy computed tomograp
21 The diagnosis of
fibrolamellar HCC was the most accurate and had the high
22 er tumors with central scars, including FNH,
fibrolamellar HCC, and large hemangioma.
23 atures that may allow confident diagnosis of
fibrolamellar HCC.
24 gs in 31 patients with histologically proved
fibrolamellar HCC.
25 central scars-including 29 cases of FNH, 20
fibrolamellar HCCs, and 15 large (>3.5 cm in diameter) h
26 ith hyalinizing trabecular tumors (HTTs) and
fibrolamellar hepatocellular carcinoma (FHCC), respectiv
27 BACKGROUND & AIMS:
Fibrolamellar hepatocellular carcinoma (FL-HCC) is a pri
28 Fibrolamellar hepatocellular carcinoma (FL-HCC) is a rar
29 oduction, and also in tumors associated with
fibrolamellar hepatocellular carcinoma (FL-HCC), a rare
30 recognized as the signature genetic event of
fibrolamellar hepatocellular carcinoma (FL-HCC), a rare
31 dentify biomarkers and candidate drivers for
fibrolamellar hepatocellular carcinoma (FL-HCC), a very
32 in, J-C subunit (J-C), becomes the driver of
fibrolamellar hepatocellular carcinoma (FL-HCC).
33 Fibrolamellar hepatocellular carcinoma (FLC) is a rare f
34 Fibrolamellar Hepatocellular Carcinoma (FLC) is a rare l
35 Fibrolamellar hepatocellular carcinoma (FLC) is a rare l
36 Fibrolamellar hepatocellular carcinoma (FLC) is a rare l
37 Fibrolamellar hepatocellular carcinoma (FLC) is a rare p
38 Fibrolamellar hepatocellular carcinoma (FLC) is a rare s
39 Fibrolamellar hepatocellular carcinoma (FLC) is a usuall
40 Fibrolamellar hepatocellular carcinoma (FLC), a typicall
41 Fibrolamellar hepatocellular carcinoma (FLHCC) tumors al
42 epresents a potential therapeutic target for
fibrolamellar hepatocellular carcinoma (FLHCC).
43 d to be useful immunohistochemical stains in
fibrolamellar hepatocellular carcinoma and may aid in th
44 Fibrolamellar hepatocellular carcinoma is a rare primary
45 e of PRKACA fusions, drive the phenotypes of
fibrolamellar hepatocellular carcinoma, reshaping unders
46 The aetiology of human
fibrolamellar hepatocellular carcinomas (hFL-HCCs), canc
47 Fibrolamellar hepatoma (FL-HCC) is an uncommon variant o
48 patocellular carcinoma (HCC), and 12 had the
fibrolamellar variant of HCC (FLL-HCC).